Brief: Acer Therapeutics Got Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
30/12/2021 21:34
Dec 30 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS INC -ON DEC 29, GOT NOTICE OF DELISTING
OR
FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ
Source text: [https://bit.ly/3JscPOD]
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31